Recent advances in diabetology: Diabetic dermopathy, autoantibodies in the prediction of the development of type 1 diabetes, and islet cell transplantation and inhaled insulin as treatment for diabetes

Clinical and Experimental Dermatology

Volumn 31, Issue 6, 2006, Pages 837-840

  Finucane, K A ^a   Archer, C B ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD3 ANTIBODY; CYCLOSPORIN; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INSULIN; INSULIN ANTIBODY; LONG ACTING INSULIN; PANCREAS ISLET CELL ANTIBODY; VACCINE;

ANTIBODY DETECTION; COUGHING; HISTOPATHOLOGY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; PANCREAS ISLET TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; REVIEW; SKIN DISEASE;

ADMINISTRATION, INHALATION; AUTOANTIBODIES; BIOLOGICAL MARKERS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DISEASE SUSCEPTIBILITY; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; SKIN DISEASES, VASCULAR;

EID: 33749821726     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02239.x     Document Type: Review

References (17)

1. Shemer A, Bergman R, Lin S et al. Diabetic dermopathy and internal complications in diabetes mellitus. Int J Dermatol 1998; 37: 113-15.
2. Huntley A, Drugge R. Diabetes in skin disease. Electronic Textbook of Dermatology, 1995-2000. Available at: http://telemedicine.org/dm/dmupdate.htm.
3. Ngo BT, Hayes KD, DiMiao DJ et al. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol 2005; 6: 225-37.
4. Huntley A. The skin and diabetes mellitus. Dermatol Online J 1995; 1. Available at: http://dermatology.cdlib.org/.
5. Wigington G, Ngo B, Rendell M. Skin blood flow in diabetic dermopathy. Arch Dermatol 2004; 140: 1248-50.
6. Achenbach P, Boniface E, Ziegler A. Predicting Type 1 diabetes. Current Diabetes Reports 2005; 5: 98-103.
7. 2, MA. Atkinson. Thirty years of investigating the autoimmune basis for Type I diabetes - why can't we prevent or reverse this disease? Diabetes 2004; 54: 1253-63.
8. Krischer JP, Cuthbertson DD, YuL et al. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 2003; 88: 103-8.
9. von Herrath MG, Dyrberg T, Oldstone MB. Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 1996; 98: 1324-31.
10. The Diabetes Prevention Trial-Type 1 Study Group. Effects of oral insulin in relatives of patients with type 1 diabetes. The Diabetes Prevention Trial -Type 1. Diabetes Care 2005; 28: 1068-76.
11. Kwang-won Kim. Islet transplantation. a realistic alternative for the treatment of insulin deficient diabetes mellitus. Diabetes Res Clin Prac 2004; 66S: S11-17.
12. Hering BJ, Kandaswamy R, Ansite JD et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830-5.
13. Rother. KI, Harlan. DM. Challenges facing islet transplantation for the treatment of type 1 diabetes. J Clin Invest 2004; 114: 114-17.
14. Gadsby R. Inhaled insulin. Update 2005; June: 71-3.
15. Quattrin T, Belanger A, Bohannon N et al. Efficacy and safety of inhaled insulin (Exubra) compared with subcutaneous insulin therapy in patients with type 1 diabetes. Diabetes Care 2004; 27: 2622-7.
16. Hollander P, Blonde L, Rowe R et al. Efficacy and safety of inhaled insulin (Exubra) compared with subcutaneous insulin therapy on patients with type 2 diabetes. Diabetes Care 2004; 27: 2356-62.
17. Rosenstock J, Cappelleri J, Bolinder B et al. Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubra) in patients with type 1 or type 2 diabetes. Diabetes Care 2004; 27: 1318-23.